AstraZeneca has announced it will invest millions in one of its state-of-the-art facilities that focuses on packing protein therapeutics in a growing area in its portfolio.
AstraZeneca has recently completed a $2.4 billion deal for a California-based pharmaceutical company that gives the company a boost in next-generation cancer treatments.
WILMINGTON – To allow the distribution of renewable natural gas to all of its facilities in the United States by the end of 2026, AstraZeneca has partnered with Vanguard Renewables. […]
WILMINGTON – Seeking to supercharge its cancer drug pipeline, pharmaceutical giant AstraZeneca announced a deal potentially worth more than $1.2 billion to acquire a small California-based biotech firm working on […]
WILMINGTON – The global pharmaceutical giant AstraZeneca recently informed employees that it is pursuing a buyout of its $1.3 billion pension plan for U.S. employees by a third-party insurer, likely […]
Premier Digital Partners
© 2024 Delaware Business Times
